Cell Impact AB (publ) (STO:CI)
Sweden
· Delayed Price · Currency is SEK 0.129
-0.005 (-3.73%)
Mar 9, 2026, 5:21 PM CET
Cell Impact AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 5.57 | 37.33 | 47.26 | 77.42 | 71.35 | Upgrade
|
| Other Revenue | 0.12 | 0.6 | 0.4 | 0.9 | 10.45 | Upgrade
|
| Revenue | 5.69 | 37.92 | 47.66 | 78.32 | 81.8 | Upgrade
|
| Revenue Growth (YoY) | -85.01% | -20.43% | -39.14% | -4.26% | 179.09% | Upgrade
|
| Cost of Revenue | 10.66 | 31.91 | 21.81 | 39.87 | 46.92 | Upgrade
|
| Gross Profit | -4.97 | 6.01 | 25.85 | 38.45 | 34.88 | Upgrade
|
| Selling, General & Admin | 46.96 | 62.27 | 120.04 | 124 | 102.68 | Upgrade
|
| Other Operating Expenses | 3.1 | 11.5 | 1.64 | 1.53 | 0.05 | Upgrade
|
| Operating Expenses | 80.24 | 105.03 | 145.34 | 141.91 | 112.92 | Upgrade
|
| Operating Income | -85.21 | -99.02 | -119.49 | -103.47 | -78.04 | Upgrade
|
| Interest Expense | -4.07 | -2.56 | -3.05 | -1.54 | -1.69 | Upgrade
|
| Interest & Investment Income | - | 1.47 | 1.18 | 0.86 | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.23 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | -0 | -0 | -0 | -0 | Upgrade
|
| EBT Excluding Unusual Items | -89.28 | -100.35 | -121.36 | -104.15 | -79.73 | Upgrade
|
| Asset Writedown | -42.7 | - | - | - | - | Upgrade
|
| Pretax Income | -131.98 | -100.35 | -121.36 | -104.15 | -79.73 | Upgrade
|
| Income Tax Expense | 0.01 | 0.09 | 0.04 | 0.07 | 0.12 | Upgrade
|
| Net Income | -131.98 | -100.43 | -121.4 | -104.22 | -79.85 | Upgrade
|
| Net Income to Common | -131.98 | -100.43 | -121.4 | -104.22 | -79.85 | Upgrade
|
| Shares Outstanding (Basic) | 169 | 62 | 11 | 8 | 6 | Upgrade
|
| Shares Outstanding (Diluted) | 169 | 62 | 11 | 8 | 6 | Upgrade
|
| Shares Change (YoY) | 173.52% | 463.84% | 44.78% | 27.89% | 17.66% | Upgrade
|
| EPS (Basic) | -0.78 | -1.62 | -11.07 | -13.76 | -13.49 | Upgrade
|
| EPS (Diluted) | -0.78 | -1.62 | -11.07 | -13.76 | -13.49 | Upgrade
|
| Free Cash Flow | -47.29 | -74.64 | -156.29 | -168.37 | -139.05 | Upgrade
|
| Free Cash Flow Per Share | -0.28 | -1.21 | -14.26 | -22.23 | -23.48 | Upgrade
|
| Gross Margin | -87.41% | 15.86% | 54.24% | 49.09% | 42.64% | Upgrade
|
| Operating Margin | -1498.66% | -261.11% | -250.70% | -132.11% | -95.40% | Upgrade
|
| Profit Margin | -2321.21% | -264.83% | -254.71% | -133.07% | -97.62% | Upgrade
|
| Free Cash Flow Margin | -831.69% | -196.81% | -327.92% | -214.98% | -169.99% | Upgrade
|
| EBITDA | -55.03 | -80.16 | -106.32 | -92.29 | -72.3 | Upgrade
|
| EBITDA Margin | - | -211.37% | -223.07% | -117.84% | -88.39% | Upgrade
|
| D&A For EBITDA | 30.19 | 18.86 | 13.17 | 11.18 | 5.74 | Upgrade
|
| EBIT | -85.21 | -99.02 | -119.49 | -103.47 | -78.04 | Upgrade
|
| EBIT Margin | - | -261.11% | -250.70% | -132.11% | -95.40% | Upgrade
|
| Revenue as Reported | 2.07 | 26.85 | 48.58 | 93.03 | 81.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.